We describe an infant with severe combined immunodeficiency syndrome and an ␣-thalassemia trait who developed a renal Fanconi syndrome after his first stem cell transplantation. This syndrome consists of a generalized failure of proximal tubular reabsorption, which leads to a large number of metabolic disturbances. The etiology varies from inherited causes, including an idiopathic form, to acquired causes such as intoxications, immunological disorders and hemoglobinopathies. In this case report we discuss possible explanations of the Fanconi syndrome in our patient. Bone Marrow Transplantation (2000) 26, 97-99. Keywords: immunodeficiency; ␣-thalassemia; bone marrow transplantation; Fanconi syndrome
The de Toni-Debré-Fanconi syndrome is characterized by a general dysfunction of the proximal tubule, leading to an excessive urinary loss of amino acids, glucose, bicarbonate, phosphate and other solutes normally absorbed in the proximal tubule. The consequences of these losses are hyperchloremic metabolic acidosis, decreased plasma phosphate levels, electrolyte imbalance, which can lead to severe dehydration, rickets, and growth retardation. The syndrome was first described by Lignac in 1924 . 1 In 1943, McCune et al 2 abbreviated the name to Fanconi syndrome. We describe a boy with severe combined immunodeficiency syndrome (SCID), ␣ 0 -thalassemia and Fanconi syndrome, a combination of rare diseases not previously reported.
Case report
A 1-month-old Turkish boy, born 20 March 1998, was admitted to our hospital in April 1998 for a cord blood transplantation from a matched unrelated donor for his RAG-2 point mutation (deletion of a guanin nucleotide at position 1913, which causes a frame shift and a stop codon at amino acid position 247) autosomal recessive SCID (non T, non B). He was born after an uneventful pregnancy and delivery from consanguineous parents (first cousins), who lost their first born female child, also affected by SCID without signs of Fanconi syndrome. The diagnosis of our patient was established from cord blood. The father was heterozygous for ␣-thalassemia (--SEA) and the mother was heterozygous for ␤-thalassemia (IVS1-6 T→C). Hbelectrophoresis of blood from our patient revealed only an ␣-thalassemia trait. He was prepared for stem cell transplantation with antithymocytic globulin 5 mg/kg/day (20 mg/day) for 5 consecutive days because of circulating maternal T cells. He received cyclosporin A to prevent GVHD. On 25 May 1998, he received 80 ml MUD-cord blood without T or B cell depletion, which contained 15.2 ϫ 10 7 NBC/kg body weight. After stem cell transplantation he was treated with methotrexate 2.5 mg/day on days ϩ1 and ϩ3 and cyclosporin A was continued for GVHD prophylaxis. There were no complications during his hospital stay. Unfortunately, no engraftment of T or B cells was documented. He remained in good physical condition with length and weight measurements at the 10th percentile. In December 1998 he received a second stem cell transplant. This time he received bone marrow from a matched unrelated donor after T and B cell depletion. During routine laboratory tests we found some abnormal findings in his blood and urine, which lead to the diagnosis of renal Fanconi syndrome. These findings were: hypophosphatemia (0.36 mmol/l), increased alkaline phosphatase (1504 U/l), hyperchloremic metabolic acidosis (Cl Ϫ 110 mmol/l with HCO 3 Ϫ 17 mmol/l), generalized aminoaciduria, glucosuria (0.7 gram%), hyperphosphaturia (27.88 mmol/l, TRP 42%), hypercalciuria (4.94 mmol/l), and ␤ 2 -microglobulinuria (113 670 g/l). An X-ray of the left hand showed cupping of some metacarpals, compatible with rickets. The family history did not reveal relatives with short stature, rickets or renal failure. Therapy with 1,25-(OH) 2 -vitamin D 3 (ethalpha) , sodium potassium phosphate, sodium bicarbonate, hydrochlorothiazide and potassium chloride corrected the blood chemistry. Today, 14 months after bone marrow transplantation, our patient is doing reasonably well. In February 1999 he received his last blood and platelet transfusions. Unfortunately, his immunologic recovery is moderate to poor. Until now, he has no B cells and his T cells are extremely low. Despite all this he did not suffer severe infections. However his renal Fanconi syndrome is becom-ing a major problem. Keeping the electrolytes in balance is a difficult task in a growing child. Once, he deteriorated severely as a result of a mild upper respiratory tract infection for which emergency admission was necessary.
Discussion
Fanconi syndrome is rare in pediatric practice. The causes are numerous (Table 1) , but the most common cause of the Fanconi syndrome in childhood is the infantile form of cystinosis. In adults, dysproteinemias, including multiple myeloma, and exogenous toxins, like heavy metals and drugs, are the most common cause of a persistent Fanconi syndrome. 3 When no identifiable cause is recognized, the disease is referred to as idiopathic, sporadic, or primary. Several different modes of inheritance have been described in cases of idiopathic Fanconi syndrome: ie autosomal dominant, 4,5 autosomal recessive, 6 and even an X-linked mode. 7 The idiopathic variety of Fanconi syndrome can only be diagnosed when all other causes are excluded. In our patient we excluded the metabolic forms of Fanconi syndrome clinically and by appropriate laboratory testing. From the acquired causes only the drug gentamicin is of interest in our patient as he received an aminoglycoside, netilmicin, during his preparation for the first stem cell transplantation. The Fanconi syndrome has not been described after use of netilmicin, but netilmicin is a nephrotoxic antibiotic similar to gentamicin. He also received methotrexate and cyclosporin A, which are also nephrotoxic drugs. None of these drugs have been described as causative factors in the Fanconi syndrome. Other acquired causes include immunological disorders. Multiple myeloma, light chain proteinuria, Sjögren's syndrome, amyloidosis, acute nephritis with antitubular basement membrane antibody and nephrotic syndrome are associated with Fanconi syndrome, but these diseases are extremely rare in children. 8 An association between an immunodeficiency and Fanconi syndrome has not been reported, though there are a few reports of renal tubular defects associated with hemoglobinopathies. 9, 10 The pathogenesis of tubular dysfunction described in patients with ␤-thalassemia/HbE disease 9,10 may also apply to other anemic states. In various forms of thalassemia shortened red cell life span, rapid iron turnover and tissue deposition of excess iron are contributing factors to functional and physiological abnormalities. Ong-ajyooth et al 9 state that iron deposition in renal tubular cells may induce lipid peroxidation as shown by an excess of malondialdehyde in blood and urine. Sumboonnanonda et al 10 suggest that the renal damage in children with ␤-thalassemia is caused by anemia and increased oxidation induced by excess iron deposits. Our patient had poor bone marrow function from birth and received several blood transfusions before and during transplantation. He certainly had a shortened red cell life span and a rapid iron turnover. Iron overloading is therefore quite possible.
In conclusion, we describe a patient with severe combined immunodeficiency syndrome and an ␣-thalassemia trait who developed a renal Fanconi syndrome after his first stem cell transplant. Most causes could be excluded by clinical and laboratory evaluation. Two possible acquired causes and the idiopathic form of Fanconi syndrome could not be excluded. Iron loading, in combination with nephrotoxic drugs, especially netilmicin, could be an explanation for the development of Fanconi syndrome. However, this male child from consanguineous parents, both of whom are heterozygous for thalassemia, suffered from the rare genetic disease SCID caused by a RAG-2 mutation and could have another inherited disorder as well. Thus, the idiopathic form of Fanconi syndrome has not been excluded. Follow-up should tell us which cause is most probable. Should the proximal tubular function recover in time, as has been shown for several cases of Fanconi syndrome by treating the underlying cause, this would suggest that the Fanconi syndrome in our patient was the result of iron deposition, probably in combination with damage by nephrotoxic drugs.
